
Big Pharma Split Corp.
PRM.TOTSXFinancial Services● Active
$13.75
+$0.12(+0.88%)
Market Cap$17933259
P/E Ratio—
52W High$15.5
52W Low$10.71
Big Pharma Split Corp.(PRM.TO)· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · PRM.TO · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $31.22M | $26.21M | $0.20M | $0.82M | $1.43M |
| Net Receivables | $0.11M | $0.10M | $0.08M | $14.00M | $0.10M |
| Inventory | $0.00M | $0.00M | $0.00M | ($0.55M) | ($0.96M) |
| Total Current Assets | $31.33M | $1.13M | $1.00M | $14.82M | $1.53M |
| PP&E Net | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Assets | $31.84M | $26.30M | $26.53M | $39.10M | $37.81M |
| Liabilities | |||||
| Short-Term Debt | $13.17M | $11.57M | $10.30M | $9.85M | $14.86M |
| Accounts Payable | $0.00M | $0.00M | $0.25M | $0.35M | $0.34M |
| Total Current Liabilities | $13.47M | $11.84M | $0.25M | $19.37M | $0.34M |
| Long-Term Debt | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Liabilities | $13.57M | $12.62M | $10.68M | $19.37M | $15.41M |
| Stockholders Equity | |||||
| Retained Earnings | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Stockholders Equity | $18.27M | $13.68M | $15.85M | $19.73M | $22.40M |
| Total Liab & Equity(computed) | $31.84M | $26.30M | $26.53M | $39.10M | $37.81M |
| Debt Summary | |||||
| Total Debt | $13.17M | $11.57M | $10.30M | $9.85M | $14.86M |
| Net Debt | $11.82M | $10.54M | $10.09M | $9.04M | $13.43M |
数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · CAD · M
深入了解Big Pharma Split Corp.
关于Big Pharma Split Corp.(PRM.TO)资产负债表
Big Pharma Split Corp.总资产$0.03B,现金及短期投资$0.03B,总负债$0.01B,总债务$0.01B,股东权益$0.02B。
常见问题
PRM.TO · 4 问Big Pharma Split Corp.总债务$0.01B,净债务$0.01B。
PRM.TO total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10